Breaking News Headlines Today | Ground News

See every side of every news story

Center for Medical Economics and Innovation image

News from Center for Medical Economics and Innovation

Your destination for news from Center for Medical Economics and Innovation. See how Center for Medical Economics and Innovation’s media bias impacts the breaking news stories of today.

Overall, we’ve indexed 5 stories from Center for Medical Economics and Innovation over the past 3 months.

We’ve assigned a media bias rating of unknown to Center for Medical Economics and Innovation. You can read more about our methodology here.

Is Center for Medical Economics and Innovation credible or reliable? Our Factuality score answers both of those questions. When it comes to Center for Medical Economics and Innovation, we’ve assigned a Unknown factuality rating. Ratings are assigned by aggregating scores from Ad Fontes Media and Media Bias/Fact Check.

Information about Center for Medical Economics and Innovation

Where is Center for Medical Economics and Innovation located?Center for Medical Economics and Innovation's Website

Media Bias Ratings

Do you diasgree?

Edit bias

Learn more about Media Bias Ratings.

Factuality

Learn more about Factuality Ratings

Reveal Factuality Ratings by upgrading to a Premium account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Ownership

Learn more about Ownership categories

Reveal Ownership Data by upgrading to a Vantage account.

Tap Upgrade to explore subscription options to meet all your reading needs.

Top Center for Medical Economics and Innovation News

Democrats, Republicans find unity on big pharma reform

United States · United States

Democrats, Republicans find unity on big pharma reform

38% Right coverage: 16 sources

(The Center Square) – A U.S. Senate hearing to examine deaths and cognitive delays caused by vaccines revealed a shared belief between Democrats and Republicans that the pharmaceutical industry lacks adequate oversight.See the Story

American Opinion: How to cut US drug prices without hurting innovation

100% Right coverage: 1 sources

The price of Wegovy, Novo Nordisk’s blockbuster weight-loss drug, is $1,349 a month in the U.S. ; in Germany , it’s $328. The U.S. price for Keytruda, a cancer treatment, is $191,000 a year; in Japan , it’s $44,000. The U.S. pays three times more for branded prescription drugs, on average, than other rich countries. It certainly looks as though Americans are getting a bad deal. The White House wants to narrow this discrepancy. Recently, health o…Donald Trump · United States See the Story

Potential U.S. Tariffs on Pharmaceuticals Expected to Have Minimal Impact on Alvotech’s Product ...

Coverage: 2 sources

REYKJAVIK, Iceland, May 07, 2025 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO) (the “Company”) a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, today issued a statement on the anticipated impact of potential tariffs…Pharma See the Story

You've scrolled to the bottom of the feed, there are no more stories.